Dr. April Rose – 2017 DCMF Award winner

The David Cornfield Melanoma Fund is proud to celebrate Dr. April Rose, Medical Oncology Resident, MD, PhD, as the 2017 co-recipient of the inaugural DCMF Award.

The DCMF Award was jointly established by the David Cornfield Melanoma Fund and the University of Toronto to support and advance melanoma research. The DCMF Award is available to residents and fellows in the Department of Medicine, or students in the Dalla Lana School of Public Health, who have demonstrated a special interest and research achievements in the field of melanoma.

Inspired by the important advances in melanoma treatments, April shifted her focus of oncology research from breast cancer to melanoma during her postgraduate work. Since that shift, April’s research has lead to first author peer-reviewed publications, international collaborations and prestigious national and international awards.

April’s research focuses on the investigation of the molecular mechanisms of cancer progression. In the past five years, April has worked on several projects aimed at optimizing targeted therapies for melanoma.

By using molecular techniques to determine how melanoma tumors adapt in response to targeted therapies, April and her team have developed combination therapy strategies that more effectively shrink and eradicate melanoma tumors in mice. They are currently working towards translating their lab-based findings into clinical trials so patients can have access to the treatments.

As a clinician scientist, April’s research findings have directly informed the care of her patients. In turn, caring for melanoma patients further motivates April’s research to significantly improve melanoma treatments.

Leave a Reply

Your email address will not be published. Required fields are marked *